{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T18:56:38Z","timestamp":1792522598605,"version":"4.5.0"},"reference-count":51,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T00:00:00Z","timestamp":1729641600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Persistent pulmonary hypertension of the newborn (PPHN) is a serious condition that affects 1\u20132 per 1,000 newborns. Scientific data report the existence of neurological developmental abnormalities between 10 and 30%, but the description of these disorders linked with this situation of cerebral hypoxia and haemodynamic failure remains poorly documented.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The main goal of this study was to describe the prevalence of neuro-psychomotor developmental disorders in children aged between one and five years old who have been hospitalised at birth in a neonatal intensive care unit for the management of PPHN.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>All of the newborns \u226534 weeks of gestational age (WGA) with PPHN, treated with inhaled nitric oxide in our neonatal intensive care unit between January 2015 and December 2019 were retrospectively enrolled. An ASQ-3 standardised questionnaire, adapted to the appropriate age (12, 24, 36, 48 and 60 months) was performed by the parents.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Fifty-five children (81% of answers) with a median age of 36 months (11\u201368), whose real age was close to the one of the questionnaire (12, 24, 36, 48 and 60 months), have been included in this study. There was 47% of pathological score [borderline: less than 1 standard deviation (SD) or suspect: less than 2SD] in at least one of the five studied domains, mainly in communication (25%) and individual and social skills (22%), despite a high overall score of 250 [220; 285] out of 300 that improved with age.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study showed a significant prevalence of neuro-psychomotor developmental disorders which justifies making more accessible a prolonged and adapted follow-up for early and multidisciplinary screening and management of these children with PPHN history. Larger cohorts are needed to better explore long term outcome of these vulnerable term neonates.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fped.2024.1450916","type":"journal-article","created":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T00:56:51Z","timestamp":1729645011000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Neurodevelopmental outcome in children between one and five years after persistent pulmonary hypertension of term and near-term newborns"],"prefix":"10.3389","volume":"12","author":[{"given":"Laetitia","family":"Atlan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lionel","family":"Berthomieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Karsenty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e9raldine","family":"Gascoin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Arnaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Breinig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,10,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e20161165","DOI":"10.1542\/peds.2016-1165","article-title":"Persistent pulmonary hypertension of the newborn in late preterm and term infants in California","volume":"139","author":"Steurer","year":"2017","journal-title":"Pediatrics"},{"key":"B2","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1542\/peds.105.1.14","article-title":"Persistent pulmonary hypertension of the newborn in the era before nitric oxide: practice variation and outcomes","volume":"105","author":"Walsh-Sukys","year":"2000","journal-title":"Pediatrics"},{"key":"B3","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.acvd.2012.12.005","article-title":"Pathophysiology of persistent pulmonary hypertension of the newborn: impact of the perinatal environment","volume":"106","author":"Storme","year":"2013","journal-title":"Arch Cardiovasc Dis"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e680","DOI":"10.1542\/neo.16-12-e680","article-title":"Persistent pulmonary hypertension of the newborn","volume":"16","author":"Lakshminrusimha","year":"2015","journal-title":"NeoReviews"},{"key":"B5","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1093\/pch\/6.10.744","article-title":"Persistent fetal circulation","volume":"6","author":"D'cunha","year":"2001","journal-title":"Paediatr Child Health"},{"key":"B6","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1016\/S0929-693X(09)75296-0","article-title":"Management of severe respiratory failure in the newborn: indication of inhaled NO","volume":"16","author":"Pennaforte","year":"2009","journal-title":"Arch Pediatr"},{"key":"B7","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jpeds.2019.06.053","article-title":"Morbidity of persistent pulmonary hypertension of the newborn in the first year of life","volume":"213","author":"Steurer","year":"2019","journal-title":"J Pediatr"},{"key":"B8","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/sj.jp.7210908","article-title":"Low-dose nitric oxide therapy for persistent pulmonary hypertension: 1-year follow-up","volume":"23","author":"Clark","year":"2003","journal-title":"J Perinatol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1067\/mpd.2000.104826","article-title":"Inhaled nitric oxide in term and near-term infants: neurodevelopmental follow-up of the neonatal inhaled nitric oxide study group (NINOS)","volume":"136","year":"2000","journal-title":"J Pediatr."},{"key":"B10","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1055\/s-0032-1310523","article-title":"Variation in the management of persistent pulmonary hypertension of the newborn: a survey of physicians in Canada, Australia, and New Zealand","volume":"29","author":"Shivananda","year":"2012","journal-title":"Am J Perinatol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/S0022-3476(98)70482-2","article-title":"Multicenter study of surfactant (beractant) use in the treatment of term infants with severe respiratory failure","volume":"132","author":"Lotze","year":"1998","journal-title":"J Pediatr"},{"key":"B12","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1056\/NEJM200002173420704","article-title":"Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn","volume":"342","author":"Clark","year":"2000","journal-title":"N Engl J Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1055\/s-0035-1551673","article-title":"Impact of respiratory morbidities on neurodevelopmental outcome of late preterm infants","volume":"32","author":"Wachtel","year":"2015","journal-title":"Am J Perinatol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"F30","DOI":"10.1136\/fn.80.1.F30","article-title":"Cerebral blood flow during treatment for pulmonary hypertension","volume":"80","author":"Kusuda","year":"1999","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1542\/peds.107.6.1351","article-title":"Child health status, neurodevelopmental outcome, and parental satisfaction in a randomized, controlled trial of nitric oxide for persistent pulmonary hypertension of the newborn","volume":"107","author":"Ellington","year":"2001","journal-title":"Pediatrics"},{"key":"B16","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1067\/mpd.2002.122730","article-title":"Neurodevelopmental and medical outcomes of persistent pulmonary hypertension in term newborns treated with nitric oxide","volume":"140","author":"Lipkin","year":"2002","journal-title":"J Pediatr"},{"key":"B17","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1824-7288-36-45","article-title":"High prevalence of minor neurologic deficits in a long-term neurodevelopmental follow-up of children with severe persistent pulmonary hypertension of the newborn: a cohort study","volume":"36","author":"Berti","year":"2010","journal-title":"Ital J Pediatr"},{"key":"B18","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/S0022-3476(97)70126-4","article-title":"Longitudinal follow-up of a cohort of newborn infants treated with inhaled nitric oxide for persistent pulmonary hypertension","volume":"131","author":"Rosenberg","year":"1997","journal-title":"J Pediatr"},{"key":"B19","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/jp.2009.139","article-title":"School-age outcomes of newborns treated for persistent pulmonary hypertension","volume":"30","author":"Rosenberg","year":"2010","journal-title":"J Perinatol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.jpeds.2006.11.065","article-title":"Early inhaled nitric oxide therapy for term and near-term newborn infants with hypoxic respiratory failure: neurodevelopmental follow-up","volume":"150","author":"Konduri","year":"2007","journal-title":"J Pediatr"},{"key":"B21","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1542\/peds.90.3.392","article-title":"Hearing and neurodevelopmental outcome in survivors of persistent pulmonary hypertension of the newborn","volume":"90","author":"Marron","year":"1992","journal-title":"Pediatrics"},{"key":"B22","first-page":"288","article-title":"Neurodevelopmental outcome following persistent pulmonary hypertension of the neonate","volume":"7","author":"Leavitt","year":"1987","journal-title":"J Perinatol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/j.1442-200X.2008.02664.x","article-title":"Developmental outcomes in persistent pulmonary hypertension treated with nitric oxide therapy","volume":"51","author":"Hosono","year":"2009","journal-title":"Pediatr Int"},{"key":"B24","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1046\/j.1442-200X.2003.01718.x","article-title":"Three-year follow up of term and near-term infants treated with inhaled nitric oxide","volume":"45","author":"Ichiba","year":"2003","journal-title":"Pediatr Int"},{"key":"B25","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1111\/j.1651-2227.2008.01065.x","article-title":"Follow-up of 5- to 11-year-old children treated for persistent pulmonary hypertension of the newborn","volume":"98","author":"Eriksen","year":"2009","journal-title":"Acta Paediatr"},{"key":"B26","first-page":"83","article-title":"Neuro-developmental follow-up of neonates treated with magnesium sulphate for persistent pulmonary hypertension","volume":"1","author":"Galli","year":"2008","journal-title":"J Neonat Perinat Med"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1093\/cercor\/bht332","article-title":"Neonatal hypoxia, hippocampal atrophy, and memory impairment: evidence of a causal sequence","volume":"25","author":"Cooper","year":"2015","journal-title":"Cereb Cortex"},{"key":"B28","volume-title":"Troubles du Neurod\u00e9veloppement: Rep\u00e9rage et Orientation des Enfants \u00e0 Risque. M\u00e9thode Recommandations Pour la Pratique Clinique","year":"2020"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1111\/dmcn.14187","article-title":"Early intervention programmes for infants at high risk of atypical neurodevelopmental outcome","volume":"61","author":"Hutchon","year":"2019","journal-title":"Dev Med Child Neurol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.clinthera.2010.04.023","article-title":"Efficacy of inhaled nitric oxide for hypoxic respiratory failure in term and late preterm infants by baseline severity of illness: a pooled analysis of three clinical trials","volume":"32","author":"Golombek","year":"2010","journal-title":"Clin Ther"},{"key":"B31","doi-asserted-by":"publisher","first-page":"e191179","DOI":"10.1001\/jamanetworkopen.2019.1179","article-title":"Evaluation of oxygen saturation index compared with oxygenation Index in neonates with hypoxemic respiratory failure","volume":"2","author":"Muniraman","year":"2019","journal-title":"JAMA Netw Open"},{"key":"B32","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1097\/PCC.0000000000000153","article-title":"Vasoactive-inotropic score is associated with outcome after infant cardiac surgery: an analysis from the pediatric cardiac critical care consortium and virtual PICU system registries","volume":"15","author":"Gaies","year":"2014","journal-title":"Pediatr Crit Care Med"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1097\/PCC.0000000000001738","article-title":"Comparing vasoactive-inotropic score reporting strategies in the PICU relative to mortality risk","volume":"19","author":"Musick","year":"2018","journal-title":"Pediatr Crit Care Med"},{"key":"B34","doi-asserted-by":"publisher","first-page":"e1468","DOI":"10.1542\/peds.2012-3313","article-title":"Validity of the ages and stages questionnaires in term and preterm infants","volume":"131","author":"Schonhaut","year":"2013","journal-title":"Pediatrics"},{"key":"B35","volume-title":"Ages & Stages Questionnaires, Third Edition: A Parent-Completed Child-Monitoring System","author":"Squires","year":"2009"},{"key":"B36","volume-title":"Avis Scientifique sur le Choix D\u2019un Outil de Mesure du D\u00e9veloppement des Enfants de 0 \u00e0 5 ans Dans le Cadre des Services Int\u00e9gr\u00e9s en P\u00e9rinatalit\u00e9 et Pour la Petite Enfance","author":"Beauregard","year":"2010"},{"key":"B37","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1093\/jpepsy\/22.3.313","article-title":"Revision of a parent-completed development screening tool: ages and stages questionnaires","volume":"22","author":"Squires","year":"1997","journal-title":"J Pediatr Psychol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"j3448","DOI":"10.1136\/bmj.j3448","article-title":"Neurodevelopmental outcome at 2 years for preterm children born at 22\u201334 weeks\u2019 gestation in France in 2011: ePIPAGE-2 cohort study","volume":"358","author":"Pierrat","year":"2017","journal-title":"Br Med J"},{"key":"B39","doi-asserted-by":"publisher","first-page":"n741","DOI":"10.1136\/bmj.n741","article-title":"Neurodevelopmental outcomes at age 5 among children born preterm: ePIPAGE-2 cohort study","volume":"373","author":"Pierrat","year":"2021","journal-title":"Br Med J"},{"key":"B40","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.perped.2022.01.020","article-title":"D\u00e9veloppement \u00e0 5 ans des enfants n\u00e9s pr\u00e9matur\u00e9s ayant b\u00e9n\u00e9fici\u00e9 d\u2019un d\u00e9pistage \u00e0 2 ans par les questionnaires ASQ et M-CHAT: cohorte EPIPAGE-2","volume":"5","author":"Torchin","year":"2022","journal-title":"Perfectionnement en P\u00e9diatrie"},{"key":"B41","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1111\/j.1440-1754.2008.01388.x","article-title":"Use of the ages and stages questionnaire to predict outcome after hypoxic-ischaemic encephalopathy in the neonate","volume":"44","author":"Lindsay","year":"2008","journal-title":"J Paediatr Child Health"},{"key":"B42","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.jpedsurg.2012.01.032","article-title":"Multi-institutional follow-up of patients with congenital diaphragmatic hernia reveals severe disability and variations in practice","volume":"47","author":"Safavi","year":"2012","journal-title":"J Pediatr Surg"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1017\/S1047951117000415","article-title":"Developmental screening in children with CHD: ages and stages questionnaires","volume":"27","author":"Noeder","year":"2017","journal-title":"Cardiol Young"},{"key":"B44","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1080\/17518423.2021.1960918","article-title":"Utility of the ages and stages questionnaires 3rd edition for developmental screening in children with surgically repaired congenital heart disease","volume":"25","author":"L\u00e9pine","year":"2022","journal-title":"Dev Neurorehabil"},{"key":"B45","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1097\/MAT.0000000000001035","article-title":"Neurodevelopmental outcomes in extracorporeal membrane oxygenation patients: a pilot study","volume":"66","author":"Dhar","year":"2020","journal-title":"ASAIO J"},{"key":"B46","doi-asserted-by":"publisher","first-page":"858154","DOI":"10.1155\/2011\/858154","article-title":"Patient characteristics in persistent pulmonary hypertension of the newborn","volume":"2011","author":"Roofthooft","year":"2011","journal-title":"Pulm Med"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1038\/s41390-023-02528-y","article-title":"ASQ-3 and BSID-III\u2019s concurrent validity and predictive ability of cognitive outcome at 5 years","volume":"94","author":"Duggan","year":"2023","journal-title":"Pediatr Res"},{"key":"B48","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1001\/jamapediatrics.2019.6000","article-title":"Comparative accuracy of developmental screening questionnaires","volume":"174","author":"Sheldrick","year":"2020","journal-title":"JAMA Pediatr"},{"key":"B49","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.earlhumdev.2011.05.007","article-title":"Ages and stages questionnaires: feasibility of postal surveys for child follow-up","volume":"87","author":"Troude","year":"2011","journal-title":"Early Hum Dev"},{"key":"B50","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.acap.2014.08.002","article-title":"Concurrent validity of the ages and stages questionnaires and bayley developmental scales in a general population sample","volume":"15","author":"Veldhuizen","year":"2015","journal-title":"Acad Pediatr"},{"key":"B51","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1093\/ije\/dyz227","article-title":"Cohort profile: the French national cohort of children (ELFE): birth to 5 years","volume":"49","author":"Charles","year":"2020","journal-title":"Int J Epidemiol"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2024.1450916\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T00:56:58Z","timestamp":1729645018000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2024.1450916\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,23]]},"references-count":51,"alternative-id":["10.3389\/fped.2024.1450916"],"URL":"https:\/\/doi.org\/10.3389\/fped.2024.1450916","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,23]]},"article-number":"1450916"}}